Paper6404446
Plasmodium malaria resistant to chloroquine in a Zambian living in Zambia.
Ekue JM and 2 others. Br Med J (Clin Res Ed), 1983. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Plasmodium malaria resistant to chloroquine in a Zambian living in Zambia. Papers, record 6404446. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6404446
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chloroquine | Major topic |
| Malaria | Major topic |
| Plasmodium falciparum | Major topic |
| Adult | |
| Drug Resistance, Microbial | |
| Female | |
| Humans | |
| Zambia |
Source PubMed
References3
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1105787 | Mefloquine (WR 142,490) in the treatment of human malaria. | Science | 1975 | https://conductscience.org/library/papers/1105787 | PubMed |
| 2 | 91887 | Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. | Lancet | 1979 | https://conductscience.org/library/papers/91887 | PubMed |
| 3 | 382468 | Chloroquine-resistant Plasmodium falciparum malaria in Kenya. | Trans R Soc Trop Med Hyg | 1979 | https://conductscience.org/library/papers/382468 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31796087 | En-route to the 'elimination' of genotypic chloroquine resistance in Western and Southern Zambia, 14 years after chloroquine withdrawal. | Malar J | 2019 | https://conductscience.org/library/papers/31796087 | PubMed |
| 31341510 | Multiple-Strain Malaria Infection and Its Impacts on Plasmodium falciparum Resistance to Antimalarial Therapy: A Mathematical Modelling Perspective. | Comput Math Methods Med | 2019 | https://conductscience.org/library/papers/31341510 | PubMed |
| 23298401 | Operational scale entomological intervention for malaria control: strategies, achievements and challenges in Zambia. | Malar J | 2013 | https://conductscience.org/library/papers/23298401 | PubMed |
| 21915314 | Insecticide resistance and the future of malaria control in Zambia. | PLoS One | 2011 | https://conductscience.org/library/papers/21915314 | PubMed |
| 21352609 | Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children. | Malar J | 2011 | https://conductscience.org/library/papers/21352609 | PubMed |
| 20162091 | Medicinal plants useful for malaria therapy in Okeigbo, Ondo State, Southwest Nigeria. | Afr J Tradit Complement Altern Med | 2006 | https://conductscience.org/library/papers/20162091 | PubMed |
| 14726463 | History, dynamics, and public health importance of malaria parasite resistance. | Clin Microbiol Rev | 2004 | https://conductscience.org/library/papers/14726463 | PubMed |
| 6397277 | The problem of Plasmodium falciparum drug resistance in Africa south of the Sahara. | Bull World Health Organ | 1984 | https://conductscience.org/library/papers/6397277 | PubMed |
| 3893778 | A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria. | Bull World Health Organ | 1985 | https://conductscience.org/library/papers/3893778 | PubMed |
| 3893777 | [Drug resistance of Plasmodium falciparum in Burundi]. | Bull World Health Organ | 1985 | https://conductscience.org/library/papers/3893777 | PubMed |
| 3311440 | A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria. | Bull World Health Organ | 1987 | https://conductscience.org/library/papers/3311440 | PubMed |
| 3311439 | Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose. | Bull World Health Organ | 1987 | https://conductscience.org/library/papers/3311439 | PubMed |
| 3081151 | Chloroquine resistant Plasmodium falciparum malaria in Zimbabwe. | Br Med J (Clin Res Ed) | 1986 | https://conductscience.org/library/papers/3081151 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6404446
GET https://conductscience.org/api/papers/v1/6404446/authors